Roche
Search results
Oct 18, 2024 · Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.
The Novartis Commitment to Patients and Caregivers. Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Learn More.
Novartis AG is a publicly traded Swiss holding company that operates through the Novartis Group and owns, directly or indirectly, all companies worldwide that operate as subsidiaries of the Novartis Group.
Search for careers at Novartis and discover our diverse and inclusive teams where we collaborate to bring innovative products to life.
Find the latest Novartis AG (NVS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Mar 15, 2024 · SINGAPORE - Swiss pharmaceutical giant Novartis is spending US$256 million (S$342.3 million) to expand its biopharmaceutical manufacturing plant here. The enlarged facility is expected to be ...
NOVARTIS (SINGAPORE) PTE LTD was incorporated on 1 August 1986 (Friday) as a Private Company Limited by Shares in Singapore. The Company current operating status is live with registered address at OCEAN FINANCIAL CENTRE.
3 days ago · Novartis expects to increase its annual sales by least 5% per year in the coming years, CEO Vas Narasimhan said in an interview on Saturday, with the pharmaceuticals giant having nothing to fear from the end of patent protection on some drugs. "I am very confident that we will achieve average growth of at least 5% per year until 2028," Narasimhan told Swiss newspaper Finanz und Wirtschaft.
Novartis Patient Assistance Foundation (NPAF) provides Novartis medication free of cost to eligible patients without insurance coverage or who cannot afford the cost of the medication.
Oct 29, 2024 · Novartis has exclusive rights to MRT-6160 and follow-up VAV1 degraders and will be responsible for development activities from phase 2 onwards, after Boston-based Monte Rosa completes its phase 1 ...
